Higher Plasma Stromal Cell-Derived Factor 1 Is Associated with Lower Risk for Sarcopenia in Older Asian Adults

Background Despite the protective effects of stromal cell-derived factor 1 (SDF-1) in stimulating muscle regeneration shown in experimental research, there is a lack of clinical studies linking circulating SDF-1 concentrations with muscle phenotypes. In order to elucidate the role of SDF-1 as a pote...

Full description

Bibliographic Details
Main Authors: Sunghwan Ji, Kyunggon Kim, So Jeong Park, Jin Young Lee, Hee-Won Jung, Hyun Ju Yoo, Il-Young Jang, Eunju Lee, Ji Yeon Baek, Beom-Jun Kim
Format: Article
Language:English
Published: Korean Endocrine Society 2023-12-01
Series:Endocrinology and Metabolism
Subjects:
Online Access:http://www.e-enm.org/upload/pdf/enm-2023-1783.pdf
_version_ 1827393484182519808
author Sunghwan Ji
Kyunggon Kim
So Jeong Park
Jin Young Lee
Hee-Won Jung
Hyun Ju Yoo
Il-Young Jang
Eunju Lee
Ji Yeon Baek
Beom-Jun Kim
author_facet Sunghwan Ji
Kyunggon Kim
So Jeong Park
Jin Young Lee
Hee-Won Jung
Hyun Ju Yoo
Il-Young Jang
Eunju Lee
Ji Yeon Baek
Beom-Jun Kim
author_sort Sunghwan Ji
collection DOAJ
description Background Despite the protective effects of stromal cell-derived factor 1 (SDF-1) in stimulating muscle regeneration shown in experimental research, there is a lack of clinical studies linking circulating SDF-1 concentrations with muscle phenotypes. In order to elucidate the role of SDF-1 as a potential biomarker reflecting human muscle health, we investigated the association of plasma SDF-1 levels with sarcopenia in older adults. Methods This cross-sectional study included 97 community-dwelling participants who underwent a comprehensive geriatric assessment at a tertiary hospital in South Korea. Sarcopenia was defined by specific cutoff values applicable to the Asian population, whereas plasma SDF-1 levels were determined using an enzyme immunoassay. Results After accounting for sex, age, and body mass index, participants with sarcopenia and low muscle mass exhibited plasma SDF-1 levels that were 21.8% and 18.3% lower than those without these conditions, respectively (P=0.008 and P=0.009, respectively). Consistently, higher plasma SDF-1 levels exhibited a significant correlation with higher skeletal muscle mass index (SMI) and gait speed (both P=0.043), and the risk of sarcopenia and low muscle mass decreased by 58% and 55% per standard deviation increase in plasma SDF-1 levels, respectively (P=0.045 and P=0.030, respectively). Furthermore, participants in the highest SDF-1 tertile exhibited significantly higher SMI compared to those in the lowest tertile (P=0.012). Conclusion These findings clinically corroborate earlier experimental discoveries highlighting the muscle anabolic effects of SDF-1 and support the potential role of circulating SDF-1 as a biomarker reflecting human muscle health in older adults.
first_indexed 2024-03-08T17:50:44Z
format Article
id doaj.art-1483bbca12874bf09589e641b061f9fd
institution Directory Open Access Journal
issn 2093-596X
2093-5978
language English
last_indexed 2024-03-08T17:50:44Z
publishDate 2023-12-01
publisher Korean Endocrine Society
record_format Article
series Endocrinology and Metabolism
spelling doaj.art-1483bbca12874bf09589e641b061f9fd2024-01-02T08:10:38ZengKorean Endocrine SocietyEndocrinology and Metabolism2093-596X2093-59782023-12-0138670170810.3803/EnM.2023.17832428Higher Plasma Stromal Cell-Derived Factor 1 Is Associated with Lower Risk for Sarcopenia in Older Asian AdultsSunghwan Ji0Kyunggon Kim1So Jeong Park2Jin Young Lee3Hee-Won Jung4Hyun Ju Yoo5Il-Young Jang6Eunju Lee7Ji Yeon Baek8Beom-Jun Kim9 Division of Geriatrics, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Division of Geriatrics, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Department of Convergence Medicine, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Division of Geriatrics, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Division of Geriatrics, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Division of Geriatrics, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KoreaBackground Despite the protective effects of stromal cell-derived factor 1 (SDF-1) in stimulating muscle regeneration shown in experimental research, there is a lack of clinical studies linking circulating SDF-1 concentrations with muscle phenotypes. In order to elucidate the role of SDF-1 as a potential biomarker reflecting human muscle health, we investigated the association of plasma SDF-1 levels with sarcopenia in older adults. Methods This cross-sectional study included 97 community-dwelling participants who underwent a comprehensive geriatric assessment at a tertiary hospital in South Korea. Sarcopenia was defined by specific cutoff values applicable to the Asian population, whereas plasma SDF-1 levels were determined using an enzyme immunoassay. Results After accounting for sex, age, and body mass index, participants with sarcopenia and low muscle mass exhibited plasma SDF-1 levels that were 21.8% and 18.3% lower than those without these conditions, respectively (P=0.008 and P=0.009, respectively). Consistently, higher plasma SDF-1 levels exhibited a significant correlation with higher skeletal muscle mass index (SMI) and gait speed (both P=0.043), and the risk of sarcopenia and low muscle mass decreased by 58% and 55% per standard deviation increase in plasma SDF-1 levels, respectively (P=0.045 and P=0.030, respectively). Furthermore, participants in the highest SDF-1 tertile exhibited significantly higher SMI compared to those in the lowest tertile (P=0.012). Conclusion These findings clinically corroborate earlier experimental discoveries highlighting the muscle anabolic effects of SDF-1 and support the potential role of circulating SDF-1 as a biomarker reflecting human muscle health in older adults.http://www.e-enm.org/upload/pdf/enm-2023-1783.pdfsarcopeniastromal cell-derived factor 1chemokinesbiomarkersmuscle mass
spellingShingle Sunghwan Ji
Kyunggon Kim
So Jeong Park
Jin Young Lee
Hee-Won Jung
Hyun Ju Yoo
Il-Young Jang
Eunju Lee
Ji Yeon Baek
Beom-Jun Kim
Higher Plasma Stromal Cell-Derived Factor 1 Is Associated with Lower Risk for Sarcopenia in Older Asian Adults
Endocrinology and Metabolism
sarcopenia
stromal cell-derived factor 1
chemokines
biomarkers
muscle mass
title Higher Plasma Stromal Cell-Derived Factor 1 Is Associated with Lower Risk for Sarcopenia in Older Asian Adults
title_full Higher Plasma Stromal Cell-Derived Factor 1 Is Associated with Lower Risk for Sarcopenia in Older Asian Adults
title_fullStr Higher Plasma Stromal Cell-Derived Factor 1 Is Associated with Lower Risk for Sarcopenia in Older Asian Adults
title_full_unstemmed Higher Plasma Stromal Cell-Derived Factor 1 Is Associated with Lower Risk for Sarcopenia in Older Asian Adults
title_short Higher Plasma Stromal Cell-Derived Factor 1 Is Associated with Lower Risk for Sarcopenia in Older Asian Adults
title_sort higher plasma stromal cell derived factor 1 is associated with lower risk for sarcopenia in older asian adults
topic sarcopenia
stromal cell-derived factor 1
chemokines
biomarkers
muscle mass
url http://www.e-enm.org/upload/pdf/enm-2023-1783.pdf
work_keys_str_mv AT sunghwanji higherplasmastromalcellderivedfactor1isassociatedwithlowerriskforsarcopeniainolderasianadults
AT kyunggonkim higherplasmastromalcellderivedfactor1isassociatedwithlowerriskforsarcopeniainolderasianadults
AT sojeongpark higherplasmastromalcellderivedfactor1isassociatedwithlowerriskforsarcopeniainolderasianadults
AT jinyounglee higherplasmastromalcellderivedfactor1isassociatedwithlowerriskforsarcopeniainolderasianadults
AT heewonjung higherplasmastromalcellderivedfactor1isassociatedwithlowerriskforsarcopeniainolderasianadults
AT hyunjuyoo higherplasmastromalcellderivedfactor1isassociatedwithlowerriskforsarcopeniainolderasianadults
AT ilyoungjang higherplasmastromalcellderivedfactor1isassociatedwithlowerriskforsarcopeniainolderasianadults
AT eunjulee higherplasmastromalcellderivedfactor1isassociatedwithlowerriskforsarcopeniainolderasianadults
AT jiyeonbaek higherplasmastromalcellderivedfactor1isassociatedwithlowerriskforsarcopeniainolderasianadults
AT beomjunkim higherplasmastromalcellderivedfactor1isassociatedwithlowerriskforsarcopeniainolderasianadults